Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures.

Kern SE.

Cancer Res. 2012 Dec 1;72(23):6097-101. doi: 10.1158/0008-5472.CAN-12-3232. Epub 2012 Nov 19. Review.

2.

Biomarker studies: a call for a comprehensive biomarker study registry.

Andre F, McShane LM, Michiels S, Ransohoff DF, Altman DG, Reis-Filho JS, Hayes DF, Pusztai L.

Nat Rev Clin Oncol. 2011 Mar;8(3):171-6. doi: 10.1038/nrclinonc.2011.4. Review.

PMID:
21364690
3.

Implications of cancer-associated systemic inflammation for biomarker studies.

Kowalewska M, Nowak R, Chechlinska M.

Biochim Biophys Acta. 2010 Dec;1806(2):163-71. doi: 10.1016/j.bbcan.2010.06.002. Epub 2010 Jun 25. Review.

PMID:
20600631
4.

Mapping ethical and social aspects of cancer biomarkers.

Blanchard A.

N Biotechnol. 2016 Dec 25;33(6):763-772. doi: 10.1016/j.nbt.2016.06.1458. Epub 2016 Jun 16. Review.

5.

Biomarker analysis for oncology.

Ma Y, Gamagedara S.

Biomark Med. 2015;9(9):845-50. doi: 10.2217/bmm.15.60. Epub 2015 Sep 2. Review.

PMID:
26330199
6.

Challenges and methodology in the incorporation of biomarkers in cancer clinical trials.

Wilhelm-Benartzi CS, Mt-Isa S, Fiorentino F, Brown R, Ashby D.

Crit Rev Oncol Hematol. 2017 Feb;110:49-61. doi: 10.1016/j.critrevonc.2016.12.008. Epub 2016 Dec 21. Review.

PMID:
28109405
7.

Discover, Develop & Validate--Advance and Prospect of Tumor Biomarkers.

Zhou Q, Hu HG, Hou L.

Clin Lab. 2015;61(11):1589-99. Review.

PMID:
26731982
8.

The cancer cell secretome: a good source for discovering biomarkers?

Pavlou MP, Diamandis EP.

J Proteomics. 2010 Sep 10;73(10):1896-906. doi: 10.1016/j.jprot.2010.04.003. Epub 2010 Apr 12. Review.

PMID:
20394844
9.

From differences in means between cases and controls to risk stratification: a business plan for biomarker development.

Wentzensen N, Wacholder S.

Cancer Discov. 2013 Feb;3(2):148-57. doi: 10.1158/2159-8290.CD-12-0196. Epub 2013 Jan 8. Review.

10.

Research on cancer diagnosis in Malaysia: current status.

Looi LM, Zubaidah Z, Cheah PL, Cheong SK, Gudum HR, Iekhsan O, Ikram SI, Jamal R, Mak JW, Othman NH, Puteri JN, Rosline H, Sabariah AR, Seow HF, Sharifah NA; Working Group on Cancer Diagnosis Research.

Malays J Pathol. 2004 Jun;26(1):13-27. Review.

PMID:
16190103
11.

Selective recognition of a saccharide-type tumor marker with natural and synthetic ligands: a new trend in cancer diagnosis.

Kejík Z, Bříza T, Králová J, Martásek P, Král V.

Anal Bioanal Chem. 2010 Nov;398(5):1865-70. doi: 10.1007/s00216-010-4124-7. Epub 2010 Sep 6. Review.

PMID:
20820999
12.

The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.

Feng Z, Kagan J, Pepe M, Thornquist M, Ann Rinaudo J, Dahlgren J, Krueger K, Zheng Y, Patriotis C, Huang Y, Sorbara L, Thompson I, Srivastava S.

Clin Chem. 2013 Jan;59(1):68-74. doi: 10.1373/clinchem.2012.185140. Epub 2012 Nov 27. Review.

13.

Validation of new cancer biomarkers: a position statement from the European group on tumor markers.

Duffy MJ, Sturgeon CM, Sölétormos G, Barak V, Molina R, Hayes DF, Diamandis EP, Bossuyt PM.

Clin Chem. 2015 Jun;61(6):809-20. doi: 10.1373/clinchem.2015.239863. Epub 2015 Apr 16. Review.

14.

[Research and development for cancer biomarker].

Nakagawa H.

Nihon Rinsho. 2012 May;70(5):743-7. Review. Japanese.

PMID:
22619995
15.

New trends in molecular biomarker discovery for breast cancer.

Radpour R, Barekati Z, Kohler C, Holzgreve W, Zhong XY.

Genet Test Mol Biomarkers. 2009 Oct;13(5):565-71. doi: 10.1089/gtmb.2009.0060. Review.

PMID:
19814613
16.

Advances in proteomic prostate cancer biomarker discovery.

Goo YA, Goodlett DR.

J Proteomics. 2010 Sep 10;73(10):1839-50. doi: 10.1016/j.jprot.2010.04.002. Epub 2010 Apr 14. Review.

PMID:
20398807
17.

Application of capillary electrophoresis for the early diagnosis of cancer.

Yang Z, Sweedler JV.

Anal Bioanal Chem. 2014 Jul;406(17):4013-31. doi: 10.1007/s00216-014-7722-y. Epub 2014 Mar 26. Review.

PMID:
24668067
18.

Biomarker discovery in ovarian cancer.

Tung CS, Wong KK, Mok SC.

Womens Health (Lond). 2008 Jan;4:27-40. doi: 10.2217/17455057.4.1.27. Review.

PMID:
19072449
19.

Emerging nanoproteomics approaches for disease biomarker detection: a current perspective.

Ray S, Reddy PJ, Choudhary S, Raghu D, Srivastava S.

J Proteomics. 2011 Nov 18;74(12):2660-81. doi: 10.1016/j.jprot.2011.04.027. Epub 2011 May 7. Review.

PMID:
21596164
20.

Translational crossroads for biomarkers.

Bast RC Jr, Lilja H, Urban N, Rimm DL, Fritsche H, Gray J, Veltri R, Klee G, Allen A, Kim N, Gutman S, Rubin MA, Hruszkewycz A.

Clin Cancer Res. 2005 Sep 1;11(17):6103-8. Review.

Supplemental Content

Support Center